Chennai-based Bafna Pharmaceuticals is eyeing African and European countries for marketing its new line of lifestyle drugs.The company has entered into a contract manufacturing agreement with a UK-based company, Somex Pharma, for supplying it Simvastatin tablets, a cholesterol-lowering drug.Bafna is also planning to enter into similar tie-ups with about five other foreign pharma companies, said Bafna Mahaveer Chand, chairman and manging director of the company, at a press meet on its forthcoming initial public offering.Apart from Simvastatin, the company will also manufacture 13 other drugs for Somex. The company intends to enter the US market after establishing itself in the European Union."We will set up offices in all the countries where we market our drugs. We will enter the US market, 18 months after our foray in the UK market, " said Chand.
